Entos Pharmaceuticals Inc

Entos Pharmaceuticals Inc

This clinical-stage biotechnology company develops nucleic acid delivery platforms and genetic medicines for pharmaceutical partners and patients with rare diseases and metabolic conditions.

Entrada Therapeutics

This biopharmaceutical company develops intracellular medicines for patients with neuromuscular and rare diseases using its proprietary endosomal escape vehicle delivery platform.

Alia Therapeutics

The company develops gene editing medicines for patients with genetic diseases.

Ensoma

This company develops in vivo genomic medicines and vector delivery platforms to engineer blood and immune cells for patients with genetic diseases and cancer.

Shape Therapeutics

The company develops programmable RNA medicines and delivery systems for patients with genetic disorders and other hard-to-treat diseases.

Sisaf

This company develops RNA delivery technologies and nucleic acid medicines for pharmaceutical partners treating rare genetic diseases and cancers.

Evox Therapeutics

This biotechnology company develops engineered exosome therapeutics to deliver genetic medicines and proteins for patients with rare diseases and neurological disorders.

Anjarium BioSciences

This company develops non-viral gene therapies and synthetic DNA vectors for patients with genetic diseases and life sciences researchers.